Cargando…

In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is an aggressive malignancy highly resistant to chemotherapy. There is an urgent need for effective therapy inasmuch as resistance, intrinsic and acquired, to conventional therapies is common. Among Pt(II) antitumor drugs, [Pt(O,O′-acac)(γ-acac)(DMS)] (Ptac2S) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Muscella, Antonella, Vetrugno, Carla, Cossa, Luca Giulio, Antonaci, Giovanna, De Nuccio, Francesco, De Pascali, Sandra Angelica, Fanizzi, Francesco Paolo, Marsigliante, Santo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091852/
https://www.ncbi.nlm.nih.gov/pubmed/27806086
http://dx.doi.org/10.1371/journal.pone.0165154
_version_ 1782464644314562560
author Muscella, Antonella
Vetrugno, Carla
Cossa, Luca Giulio
Antonaci, Giovanna
De Nuccio, Francesco
De Pascali, Sandra Angelica
Fanizzi, Francesco Paolo
Marsigliante, Santo
author_facet Muscella, Antonella
Vetrugno, Carla
Cossa, Luca Giulio
Antonaci, Giovanna
De Nuccio, Francesco
De Pascali, Sandra Angelica
Fanizzi, Francesco Paolo
Marsigliante, Santo
author_sort Muscella, Antonella
collection PubMed
description Malignant pleural mesothelioma (MPM) is an aggressive malignancy highly resistant to chemotherapy. There is an urgent need for effective therapy inasmuch as resistance, intrinsic and acquired, to conventional therapies is common. Among Pt(II) antitumor drugs, [Pt(O,O′-acac)(γ-acac)(DMS)] (Ptac2S) has recently attracted considerable attention due to its strong in vitro and in vivo antiproliferative activity and reduced toxicity. The purpose of this study was to examine the efficacy of Ptac2S treatment in MPM. We employed the ZL55 human mesothelioma cell line in vitro and in a murine xenograft model in vivo, to test the antitumor activity of Ptac2S. Cytotoxicity assays and Western blottings of different apoptosis and survival proteins were thus performed. Ptac2S increases MPM cell death in vitro and in vivo compared with cisplatin. Ptac2S was more efficacious than cisplatin also in inducing apoptosis characterized by: (a) mitochondria depolarization, (b) increase of bax expression and its cytosol-to-mitochondria translocation and decrease of Bcl-2 expression, (c) activation of caspase-7 and -9. Ptac2S activated full-length PKC-δ and generated a PKC-δ fragment. Full-length PKC-δ translocated to the nucleus and membrane, whilst PKC-δ fragment concentrated to mitochondria. Ptac2S was also responsible for the PKC-ε activation that provoked phosphorylation of p38. Both PKC-δ and PKC-ε inhibition (by PKC–siRNA) reduced the apoptotic death of ZL55 cells. Altogether, our results confirm that Ptac2S is a promising therapeutic agent for malignant mesothelioma, providing a solid starting point for its validation as a suitable candidate for further pharmacological testing.
format Online
Article
Text
id pubmed-5091852
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50918522016-11-15 In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma Muscella, Antonella Vetrugno, Carla Cossa, Luca Giulio Antonaci, Giovanna De Nuccio, Francesco De Pascali, Sandra Angelica Fanizzi, Francesco Paolo Marsigliante, Santo PLoS One Research Article Malignant pleural mesothelioma (MPM) is an aggressive malignancy highly resistant to chemotherapy. There is an urgent need for effective therapy inasmuch as resistance, intrinsic and acquired, to conventional therapies is common. Among Pt(II) antitumor drugs, [Pt(O,O′-acac)(γ-acac)(DMS)] (Ptac2S) has recently attracted considerable attention due to its strong in vitro and in vivo antiproliferative activity and reduced toxicity. The purpose of this study was to examine the efficacy of Ptac2S treatment in MPM. We employed the ZL55 human mesothelioma cell line in vitro and in a murine xenograft model in vivo, to test the antitumor activity of Ptac2S. Cytotoxicity assays and Western blottings of different apoptosis and survival proteins were thus performed. Ptac2S increases MPM cell death in vitro and in vivo compared with cisplatin. Ptac2S was more efficacious than cisplatin also in inducing apoptosis characterized by: (a) mitochondria depolarization, (b) increase of bax expression and its cytosol-to-mitochondria translocation and decrease of Bcl-2 expression, (c) activation of caspase-7 and -9. Ptac2S activated full-length PKC-δ and generated a PKC-δ fragment. Full-length PKC-δ translocated to the nucleus and membrane, whilst PKC-δ fragment concentrated to mitochondria. Ptac2S was also responsible for the PKC-ε activation that provoked phosphorylation of p38. Both PKC-δ and PKC-ε inhibition (by PKC–siRNA) reduced the apoptotic death of ZL55 cells. Altogether, our results confirm that Ptac2S is a promising therapeutic agent for malignant mesothelioma, providing a solid starting point for its validation as a suitable candidate for further pharmacological testing. Public Library of Science 2016-11-02 /pmc/articles/PMC5091852/ /pubmed/27806086 http://dx.doi.org/10.1371/journal.pone.0165154 Text en © 2016 Muscella et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Muscella, Antonella
Vetrugno, Carla
Cossa, Luca Giulio
Antonaci, Giovanna
De Nuccio, Francesco
De Pascali, Sandra Angelica
Fanizzi, Francesco Paolo
Marsigliante, Santo
In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma
title In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma
title_full In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma
title_fullStr In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma
title_full_unstemmed In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma
title_short In Vitro and In Vivo Antitumor Activity of [Pt(O,O′-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma
title_sort in vitro and in vivo antitumor activity of [pt(o,o′-acac)(γ-acac)(dms)] in malignant pleural mesothelioma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091852/
https://www.ncbi.nlm.nih.gov/pubmed/27806086
http://dx.doi.org/10.1371/journal.pone.0165154
work_keys_str_mv AT muscellaantonella invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma
AT vetrugnocarla invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma
AT cossalucagiulio invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma
AT antonacigiovanna invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma
AT denucciofrancesco invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma
AT depascalisandraangelica invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma
AT fanizzifrancescopaolo invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma
AT marsigliantesanto invitroandinvivoantitumoractivityofptooacacgacacdmsinmalignantpleuralmesothelioma